These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9496417)

  • 1. Levofloxacin for drug-resistant Mycobacterium tuberculosis.
    Peloquin CA; Berning SE; Huitt GA; Iseman MD
    Ann Pharmacother; 1998 Feb; 32(2):268-9. PubMed ID: 9496417
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report.
    Berning SE; Cherry TA; Iseman MD
    Clin Infect Dis; 2001 Feb; 32(4):643-6. PubMed ID: 11181130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levofloxacin in the treatment of drug-resistant tuberculosis.
    Yew WW; Au KF; Lee J; Chau CH
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):89. PubMed ID: 9441068
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro antituberculous activity of ofloxacin and levofloxacin against multidrug-resistant tuberculosis and clinical outcomes].
    Tada A; Kawata N; Shibayama T; Takahashi S; Hirano A; Kimura G; Takeuchi M; Okada C; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):337-44. PubMed ID: 16715942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy of drug-resistant tuberculosis with inclusion of ofloxacin (zanocin)].
    Padeĭskaia EN
    Antibiot Khimioter; 2001; 46(8):9-18. PubMed ID: 11871320
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS; Koh WJ; Kwon OJ; Cho SN; Shim TS
    Int J Antimicrob Agents; 2009 Jan; 33(1):92-3. PubMed ID: 18789655
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong.
    Yew WW; Chan CK; Leung CC; Chau CH; Tam CM; Wong PC; Lee J
    Chest; 2003 Oct; 124(4):1476-81. PubMed ID: 14555582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Pracharktam R; Angkananukool K; Vibhagool A
    J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of the drug tavanik (levofloxacin) in acute and maxillary sinusitis].
    Kriukov AI; Sedinkin AA; Gerasimov KV
    Vestn Otorinolaringol; 2003; (1):30-1. PubMed ID: 12666597
    [No Abstract]   [Full Text] [Related]  

  • 11. [Levofloxacin (Tavanic) in the treatment of corneal ulcers].
    Maĭchuk IuF
    Antibiot Khimioter; 2003; 48(6):16-9. PubMed ID: 14558414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chulavatnatol S; Chindavijak B; Chierakul N; Klomsawat D
    J Med Assoc Thai; 2003 Aug; 86(8):781-8. PubMed ID: 12948278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases.
    Chauny JV; Lorrot M; Prot-Labarthe S; De Lauzanne A; Doit C; Géréral T; Bourdon O
    Pediatr Infect Dis J; 2012 Dec; 31(12):1309-11. PubMed ID: 22814964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of ofloxacin (zanocin) in the treatment of multidrug resistant pulmonary tuberculosis].
    Mishin VIu; Vasil'eva IA
    Antibiot Khimioter; 2003; 48(8):7-10. PubMed ID: 14722936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of extensive drug resistance during treatment for multidrug-resistant tuberculosis.
    Cox HS; Sibilia K; Feuerriegel S; Kalon S; Polonsky J; Khamraev AK; Rüsch-Gerdes S; Mills C; Niemann S
    N Engl J Med; 2008 Nov; 359(22):2398-400. PubMed ID: 19038891
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sensitivity of Mycobacterium tuberculosis to levofloxacin].
    Vishnevskiĭ BI; Istomin EA; Miakotina EN
    Antibiot Khimioter; 2002; 47(6):28-30. PubMed ID: 12422645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
    Chierakul N; Klomsawat D; Chulavatnatol S; Chindavijak B
    Int J Tuberc Lung Dis; 2001 Mar; 5(3):278-82. PubMed ID: 11326828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolones and tuberculosis.
    Yew WW; Chau CH
    Int J Tuberc Lung Dis; 1998 Dec; 2(12):1050-2. PubMed ID: 9869128
    [No Abstract]   [Full Text] [Related]  

  • 19. Levofloxacin-warfarin interaction.
    Gheno G; Cinetto L
    Eur J Clin Pharmacol; 2001 Aug; 57(5):427. PubMed ID: 11599661
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
    von Gottberg A; Klugman KP; Cohen C; Wolter N; de Gouveia L; du Plessis M; Mpembe R; Quan V; Whitelaw A; Hoffmann R; Govender N; Meiring S; Smith AM; Schrag S;
    Lancet; 2008 Mar; 371(9618):1108-13. PubMed ID: 18359074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.